A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
Clinical trial NCT06637371 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06637371
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-16
- Primary completion
- 2027-04-10
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.